Results 21 to 30 of about 170,023 (183)
Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection
Frontiers in Immunology, 2022 Type I Interferons (IFNs), including numerous IFNα subtypes and IFNβ, are key molecules during innate and adaptive immune responses against viral infections.
Mara Schwerdtfeger +11 more
doaj +1 more source
THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
Педиатрическая фармакология, 2011 It is known that the interferon beta therapy is more effective for multiple sclerosis. The literature review focuses on the problem of neutralizing antibodies (NAbs) in interferon beta therapy of multiple sclerosis for children and adolescents.
B.I. Bursagova +3 more
doaj +2 more sources
Some biological properties of the human amniotic membrane interferon
Memorias do Instituto Oswaldo Cruz, 1992 Human amniotic interferon was investigated to define the species specificity of its antiviral action and compare its anti-cellular and NK cell stimulating activities with those of other human interferons.
P. C. P. Ferreira +3 more
doaj +1 more source
Pediatrics and Neonatology, 2021 Background: Enteroviral meningitis is typically diagnosed as the presence of pleocytosis and of viral RNA in cerebrospinal fluid. However, it was recently reported that more than 50% of infants with enteroviral meningitis diagnosed by polymerase chain ...
Kyung Yeon Lee +3 more
doaj +1 more source
Life, 2022 Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscular (im) treatment is an uncommon adverse effect with only a few cases in multiple sclerosis patients reported worldwide.
Cristina-Florentina Plesa +6 more
doaj +1 more source
The Therapeutic Effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study [PDF]
Acta Medica Iranica, 2010 We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS). Ninety patients referring to Farshchian Hospital were entered in this study.
Mehrdokht Mazdeh +2 more
doaj +1 more source
Phylogenetic and In Silico Analysis of Interferon Beta-1b Protein
Journal of Mazandaran University of Medical Sciences, 2017 Background and purpose: Interferon beta-1b recombinant protein is used for reducing the relapse rate and treatment in patients with Multiple sclerosis (MS).
Ziaeddin Mirhoseini +2 more
doaj
Trials, 2009 Background Statins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial.
Mattle Heinrich P, Kamm Christian P
doaj +1 more source
The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes
Frontiers in Endocrinology, 2023 The hyperexpression of human leukocyte antigen class I (HLA-I) molecules on pancreatic beta-cells is widely accepted as a hallmark feature of type 1 diabetes pathogenesis. This response is important clinically since it may increase the visibility of beta-
Mark A. Russell +2 more
doaj +1 more source
1122 Radiotherapy-activated NBTXR3 nanoparticles induce interferon beta secretion by cancer cells [PDF]
, 2022 Jordan Da Silva, Sébastien Paris
openalex +1 more source